Titre : Cathéters urinaires

Cathéters urinaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cathéters urinaires : Questions médicales les plus fréquentes", "headline": "Cathéters urinaires : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cathéters urinaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-15", "dateModified": "2025-05-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cathéters urinaires" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cathéters", "url": "https://questionsmedicales.fr/mesh/D057785", "about": { "@type": "MedicalCondition", "name": "Cathéters", "code": { "@type": "MedicalCode", "code": "D057785", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E07.132" } } }, "about": { "@type": "MedicalCondition", "name": "Cathéters urinaires", "alternateName": "Urinary Catheters", "code": { "@type": "MedicalCode", "code": "D062885", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jennifer Meddings", "url": "https://questionsmedicales.fr/author/Jennifer%20Meddings", "affiliation": { "@type": "Organization", "name": "Division of General Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA; Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA; Division of General Pediatrics, Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: meddings@med.umich.edu." } }, { "@type": "Person", "name": "Barbara W Trautner", "url": "https://questionsmedicales.fr/author/Barbara%20W%20Trautner", "affiliation": { "@type": "Organization", "name": "Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, 2450 Holcombe Boulevard, Suite 01Y, Houston, TX 77021, USA; Department of Medicine, Section of Health Services Research, Baylor College of Medicine, Houston, TX, USA." } }, { "@type": "Person", "name": "Nour El Husseini", "url": "https://questionsmedicales.fr/author/Nour%20El%20Husseini", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology and Molecular Genetics, University of Maryland at College Park, College Park, MD 20742." } }, { "@type": "Person", "name": "Jared A Carter", "url": "https://questionsmedicales.fr/author/Jared%20A%20Carter", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology and Molecular Genetics, University of Maryland at College Park, College Park, MD 20742." } }, { "@type": "Person", "name": "Vincent T Lee", "url": "https://questionsmedicales.fr/author/Vincent%20T%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology and Molecular Genetics, University of Maryland at College Park, College Park, MD 20742." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Atypical emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia: a case report.", "datePublished": "2022-08-19", "url": "https://questionsmedicales.fr/article/36415340", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.11604/pamj.2022.42.295.29442" } }, { "@type": "ScholarlyArticle", "name": "Skin fibrosis associated with keloid, scleroderma and Jorge Lobo's disease (lacaziosis): An immuno-histochemical study.", "datePublished": "2022-10-01", "url": "https://questionsmedicales.fr/article/36183172", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/iep.12456" } }, { "@type": "ScholarlyArticle", "name": "Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis.", "datePublished": "2023-03-17", "url": "https://questionsmedicales.fr/article/36931690", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bcr-2022-253735" } }, { "@type": "ScholarlyArticle", "name": "UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36706594", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2023.109764" } }, { "@type": "ScholarlyArticle", "name": "[Juvenile localized scleroderma].", "datePublished": "2024-01-19", "url": "https://questionsmedicales.fr/article/38240812", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00105-023-05293-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Équipement et fournitures", "item": "https://questionsmedicales.fr/mesh/D004864" }, { "@type": "ListItem", "position": 3, "name": "Cathéters", "item": "https://questionsmedicales.fr/mesh/D057785" }, { "@type": "ListItem", "position": 4, "name": "Cathéters urinaires", "item": "https://questionsmedicales.fr/mesh/D062885" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cathéters urinaires - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cathéters urinaires", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cathéters urinaires", "description": "Comment diagnostiquer une obstruction urinaire ?\nQuels tests pour évaluer une infection urinaire ?\nQuels signes indiquent un besoin de cathéter ?\nComment évaluer la fonction vésicale ?\nQuand utiliser un cathéter à demeure ?", "url": "https://questionsmedicales.fr/mesh/D062885?mesh_terms=Scleroderma,+Localized&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cathéters urinaires", "description": "Quels symptômes d'une infection liée au cathéter ?\nComment reconnaître une irritation urinaire ?\nQuels signes d'une obstruction du cathéter ?\nQuels symptômes d'une lésion vésicale ?\nQuels symptômes d'une fuite autour du cathéter ?", "url": "https://questionsmedicales.fr/mesh/D062885?mesh_terms=Scleroderma,+Localized&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cathéters urinaires", "description": "Comment prévenir les infections urinaires ?\nQuelles mesures pour éviter l'obstruction ?\nComment réduire le risque de lésion vésicale ?\nQuelles pratiques pour un bon soin du cathéter ?\nComment éduquer les patients sur l'utilisation du cathéter ?", "url": "https://questionsmedicales.fr/mesh/D062885?mesh_terms=Scleroderma,+Localized&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cathéters urinaires", "description": "Comment traiter une infection urinaire liée au cathéter ?\nQuel soin pour un cathéter à demeure ?\nComment gérer une obstruction du cathéter ?\nQuand retirer un cathéter ?\nQuel traitement pour une irritation urinaire ?", "url": "https://questionsmedicales.fr/mesh/D062885?mesh_terms=Scleroderma,+Localized&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cathéters urinaires", "description": "Quelles sont les complications possibles des cathéters ?\nComment gérer une infection liée au cathéter ?\nQuels risques d'une utilisation prolongée ?\nComment prévenir les complications liées au cathéter ?\nQuels signes d'une complication grave ?", "url": "https://questionsmedicales.fr/mesh/D062885?mesh_terms=Scleroderma,+Localized&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cathéters urinaires", "description": "Quels facteurs augmentent le risque d'infection ?\nComment le sexe influence-t-il le risque d'infection ?\nQuels médicaments augmentent le risque d'infection ?\nQuel rôle joue l'hygiène dans le risque d'infection ?\nComment l'hospitalisation influence-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D062885?mesh_terms=Scleroderma,+Localized&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une obstruction urinaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen physique et des tests d'imagerie comme l'échographie peuvent aider." } }, { "@type": "Question", "name": "Quels tests pour évaluer une infection urinaire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Une analyse d'urine et une culture urinaire sont essentielles pour le diagnostic." } }, { "@type": "Question", "name": "Quels signes indiquent un besoin de cathéter ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Difficulté à uriner, rétention urinaire ou besoin de surveillance post-opératoire." } }, { "@type": "Question", "name": "Comment évaluer la fonction vésicale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests urodynamiques mesurent la pression et le flux urinaire." } }, { "@type": "Question", "name": "Quand utiliser un cathéter à demeure ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "En cas de rétention urinaire chronique ou de soins palliatifs prolongés." } }, { "@type": "Question", "name": "Quels symptômes d'une infection liée au cathéter ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur au bas-ventre, et urine trouble ou malodorante." } }, { "@type": "Question", "name": "Comment reconnaître une irritation urinaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Brûlures lors de la miction et besoin fréquent d'uriner peuvent indiquer une irritation." } }, { "@type": "Question", "name": "Quels signes d'une obstruction du cathéter ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Diminution du flux urinaire ou absence d'urine dans le sac de drainage." } }, { "@type": "Question", "name": "Quels symptômes d'une lésion vésicale ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Douleur pelvienne, sang dans les urines, et difficulté à uriner." } }, { "@type": "Question", "name": "Quels symptômes d'une fuite autour du cathéter ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Présence d'urine autour du site d'insertion et inconfort localisé." } }, { "@type": "Question", "name": "Comment prévenir les infections urinaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des techniques aseptiques lors de l'insertion et changer régulièrement le cathéter." } }, { "@type": "Question", "name": "Quelles mesures pour éviter l'obstruction ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Assurer un drainage adéquat et éviter les plis dans le cathéter." } }, { "@type": "Question", "name": "Comment réduire le risque de lésion vésicale ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des cathéters adaptés et surveiller régulièrement l'état du patient." } }, { "@type": "Question", "name": "Quelles pratiques pour un bon soin du cathéter ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Nettoyage quotidien et vérification de la position du cathéter pour éviter les complications." } }, { "@type": "Question", "name": "Comment éduquer les patients sur l'utilisation du cathéter ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informer sur les signes d'infection et l'importance de l'hygiène." } }, { "@type": "Question", "name": "Comment traiter une infection urinaire liée au cathéter ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Antibiotiques appropriés et, si nécessaire, remplacement du cathéter." } }, { "@type": "Question", "name": "Quel soin pour un cathéter à demeure ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Nettoyage régulier du site d'insertion et surveillance des signes d'infection." } }, { "@type": "Question", "name": "Comment gérer une obstruction du cathéter ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Déterminer la cause et éventuellement remplacer ou irriguer le cathéter." } }, { "@type": "Question", "name": "Quand retirer un cathéter ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dès que possible, lorsque la fonction vésicale est rétablie ou en cas d'infection." } }, { "@type": "Question", "name": "Quel traitement pour une irritation urinaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Hydratation accrue et éventuellement des analgésiques pour soulager la douleur." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des cathéters ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Infections, obstructions, et lésions vésicales sont des complications fréquentes." } }, { "@type": "Question", "name": "Comment gérer une infection liée au cathéter ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Remplacer le cathéter et administrer des antibiotiques selon la culture." } }, { "@type": "Question", "name": "Quels risques d'une utilisation prolongée ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Augmentation du risque d'infections et de lésions tissulaires." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au cathéter ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Surveillance régulière et soins appropriés du site d'insertion sont essentiels." } }, { "@type": "Question", "name": "Quels signes d'une complication grave ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, douleur intense, ou saignement nécessitent une attention médicale immédiate." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Âge avancé, diabète, et antécédents d'infections urinaires sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment le sexe influence-t-il le risque d'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes ont un risque plus élevé d'infections urinaires en raison de l'anatomie." } }, { "@type": "Question", "name": "Quels médicaments augmentent le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les immunosuppresseurs et certains antibiotiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Quel rôle joue l'hygiène dans le risque d'infection ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise hygiène peut augmenter le risque d'infections urinaires liées au cathéter." } }, { "@type": "Question", "name": "Comment l'hospitalisation influence-t-elle le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les patients hospitalisés sont plus exposés aux infections nosocomiales, y compris urinaires." } } ] } ] }

Sources (10000 au total)

Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.

Among individuals with systemic sclerosis (SSc) randomized to cyclophosphamide (CYC) (n = 34) or hematopoietic stem cell transplantation (HSCT) (n = 33), we examined longitudinal trends of clinical, p... Assuming that data were missing at random, mixed-effects regression models were used to estimate longitudinal trends for clinical measures when comparing treatment groups. Results were compared to obs... Available observed means for pulmonary function tests appeared to improve over time in both arms. However, after accounting for participant loss, forced vital capacity in HSCT recipients increased by ... Longitudinal trends estimated from 2 statistical models affirm the efficacy of HSCT over CYC in severe SSc. Failure to account for early loss of participants may distort estimated clinical trends over...

Development of Pulmonary Hypertension in Over One-Third of Patients With Th/To Antibody-Positive Scleroderma in Long-Term Follow-Up.

This study was undertaken to describe clinical manifestations in patients with Th/To antibody-positive systemic sclerosis (SSc) during long-term follow-up.... We performed a case-control study involving anti-Th/To antibody-positive patients with SSc who were newly referred to the University of Pittsburgh Medical Center and the Pittsburgh Scleroderma Center ... A total of 204 anti-Th/To antibody-positive SSc patients and 408 controls were identified. The cohort had a mean ± SD age of 52 ± 12.9 years, and 76% of individuals were women. Anti-Th/To antibody-pos... This is the largest cohort of patients with anti-Th/To antibody-positive SSc with long-term follow-up data. The very high rate (38%) and associated independent risk of anti-Th/To antibody-positive pat...

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with... Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi... Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0... Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....

Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized scleroderma Total Severity Scale (LoTSS).

Juvenile localized scleroderma (jLS) is a chronic autoimmune disease commonly associated with poor outcome, including contractures, hemi-atrophy, uveitis, and seizures. Despite improvements in treatme... LoTSS was developed as a weighted measure by a consensus process involving literature review, surveys, case vignettes, and multi-criteria decision analysis. Feasibility was assessed in larger Childhoo... LoTSS severity items were organized into modules that reflect jLS disease patterns, with modules for skin, extracutaneous, and craniofacial manifestations. Construct validity of LoTSS was supported by... We developed a new LS measure for assessing cutaneous and extracutaneous severity, and have shown it to be reliable, valid, and responsive. LoTSS is the first measure that assesses and scores all the ...

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.

Systemic Sclerosis (SSc) is frequently associated with gastrointestinal tract (GIT) involvement. The Collaborative National Quality and Efficacy Registry (CONQUER) is a US-based collaborative study co... CONQUER participants that had completed a minimum of two serial Scleroderma Clinical Trials Consortium GIT Questionnaires (GIT 2.0) were included in this analysis. Patients were categorised by total G... 415 enrolled CONQUER participants met project inclusion criteria. Most participants had stable mild GIT symptoms at baseline and were on immunomodulatory and anti-reflux therapy. In most patients, ant... This report from the CONQUER cohort, suggests that most patients with early SSc have stable and mild GIT disease. Closer follow-up was associated with milder, stable GIT symptoms. There was no clear a...